Literature references that cite this PDB file's
key reference
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
G.Pascreau,
F.Eckerdt,
M.E.Churchill,
and
J.L.Maller
(2010).
Discovery of a distinct domain in cyclin A sufficient for centrosomal localization independently of Cdk binding.
|
| |
Proc Natl Acad Sci U S A, 107,
2932-2937.
|
 |
|
|
|
|
 |
A.Via,
C.M.Gould,
C.Gemünd,
T.J.Gibson,
and
M.Helmer-Citterich
(2009).
A structure filter for the Eukaryotic Linear Motif Resource.
|
| |
BMC Bioinformatics, 10,
351.
|
 |
|
|
|
|
 |
G.Kontopidis,
M.J.Andrews,
C.McInnes,
A.Plater,
L.Innes,
S.Renachowski,
A.Cowan,
and
P.M.Fischer
(2009).
Truncation and optimisation of peptide inhibitors of cyclin-dependent kinase 2-cyclin a through structure-guided design.
|
| |
ChemMedChem, 4,
1120-1128.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Orzáez,
A.Gortat,
L.Mondragón,
O.Bachs,
and
E.Pérez-Payá
(2009).
ATP-noncompetitive inhibitors of CDK-cyclin complexes.
|
| |
ChemMedChem, 4,
19-24.
|
 |
|
|
|
|
 |
S.Tyagi,
and
W.Herr
(2009).
E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases.
|
| |
EMBO J, 28,
3185-3195.
|
 |
|
|
|
|
 |
A.C.Joerger,
and
A.R.Fersht
(2008).
Structural biology of the tumor suppressor p53.
|
| |
Annu Rev Biochem, 77,
557-582.
|
 |
|
|
|
|
 |
C.J.Oldfield,
J.Meng,
J.Y.Yang,
M.Q.Yang,
V.N.Uversky,
and
A.K.Dunker
(2008).
Flexible nets: disorder and induced fit in the associations of p53 and 14-3-3 with their partners.
|
| |
BMC Genomics, 9,
S1.
|
 |
|
|
|
|
 |
G.Lolli,
and
L.N.Johnson
(2007).
Recognition of Cdk2 by Cdk7.
|
| |
Proteins, 67,
1048-1059.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.GawliĆski,
R.Nikolay,
C.Goursot,
S.Lawo,
B.Chaurasia,
H.M.Herz,
Y.Kussler-Schneider,
T.Ruppert,
M.Mayer,
and
J.Grosshans
(2007).
The Drosophila mitotic inhibitor Frühstart specifically binds to the hydrophobic patch of cyclins.
|
| |
EMBO Rep, 8,
490-496.
|
 |
|
|
|
|
 |
J.Sridhar,
N.Akula,
and
N.Pattabiraman
(2006).
Selectivity and potency of cyclin-dependent kinase inhibitors.
|
| |
AAPS J, 8,
E204-E221.
|
 |
|
|
|
|
 |
K.Y.Cheng,
M.E.Noble,
V.Skamnaki,
N.R.Brown,
E.D.Lowe,
L.Kontogiannis,
K.Shen,
P.A.Cole,
G.Siligardi,
and
L.N.Johnson
(2006).
The role of the phospho-CDK2/cyclin A recruitment site in substrate recognition.
|
| |
J Biol Chem, 281,
23167-23179.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Otyepka,
I.Bártová,
Z.Kríz,
and
J.Koca
(2006).
Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics.
|
| |
J Biol Chem, 281,
7271-7281.
|
 |
|
|
|
|
 |
N.Canela,
M.Orzáez,
R.Fucho,
F.Mateo,
R.Gutierrez,
A.Pineda-Lucena,
O.Bachs,
and
E.Pérez-Payá
(2006).
Identification of an hexapeptide that binds to a surface pocket in cyclin A and inhibits the catalytic activity of the complex cyclin-dependent kinase 2-cyclin A.
|
| |
J Biol Chem, 281,
35942-35953.
|
 |
|
|
|
|
 |
R.P.Bhattacharyya,
A.Reményi,
B.J.Yeh,
and
W.A.Lim
(2006).
Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits.
|
| |
Annu Rev Biochem, 75,
655-680.
|
 |
|
|
|
|
 |
C.Gondeau,
S.Gerbal-Chaloin,
P.Bello,
G.Aldrian-Herrada,
M.C.Morris,
and
G.Divita
(2005).
Design of a novel class of peptide inhibitors of cyclin-dependent kinase/cyclin activation.
|
| |
J Biol Chem, 280,
13793-13800.
|
 |
|
|
|
|
 |
R.Honda,
E.D.Lowe,
E.Dubinina,
V.Skamnaki,
A.Cook,
N.R.Brown,
and
L.N.Johnson
(2005).
The structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2-independent roles.
|
| |
EMBO J, 24,
452-463.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Gildor,
R.Shemer,
A.Atir-Lande,
and
D.Kornitzer
(2005).
Coevolution of cyclin Pcl5 and its substrate Gcn4.
|
| |
Eukaryot Cell, 4,
310-318.
|
 |
|
|
|
|
 |
G.M.Verkhivker
(2004).
Protein conformational transitions coupled to binding in molecular recognition of unstructured proteins: hierarchy of structural loss from all-atom Monte Carlo simulations of p27Kip1 unfolding-unbinding and structural determinants of the binding mechanism.
|
| |
Biopolymers, 75,
420-433.
|
 |
|
|
|
|
 |
N.J.Dibb,
S.M.Dilworth,
and
C.D.Mol
(2004).
Switching on kinases: oncogenic activation of BRAF and the PDGFR family.
|
| |
Nat Rev Cancer, 4,
718-727.
|
 |
|
|
|
|
 |
N.Kannan,
and
A.F.Neuwald
(2004).
Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha.
|
| |
Protein Sci, 13,
2059-2077.
|
 |
|
|
|
|
 |
E.De Moliner,
N.R.Brown,
and
L.N.Johnson
(2003).
Alternative binding modes of an inhibitor to two different kinases.
|
| |
Eur J Biochem, 270,
3174-3181.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Y.Cheng,
E.D.Lowe,
J.Sinclair,
E.A.Nigg,
and
L.N.Johnson
(2003).
The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex.
|
| |
EMBO J, 22,
5757-5768.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|